Skip to search formSkip to main contentSkip to account menu

Methaqualone

Known as: 2-Methyl-3-o-tolyl-4(3H)-quinazolinone, MAOA, 2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone 
A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
A double antibody sandwich enzyme-linked immunosorbent assay (ELISA) was developed in order to improve the diagnostic of the… 
1985
1985
Abuse of the hypnotic quinazolinone is well recognized and increasing. Clandestine laboratories producing methaqualone (2-methyl… 
1981
1981
Fifteen patients with severe drug intoxication have been treated by a procedure combining hemoperfusion (HP, cellulose-coated… 
Review
1981
Review
1981
Sixty cases of methaqualone ingestion have been reviewed from 1977 through 1980. Serum methaqualone concentrations, clinical… 
1977
1977
Spin-labeled hydroxyamphetamine, a competitive reversible inhibitor of brain monoamine oxidase, has been shown to be useful as an… 
Review
1974
Review
1974
Methaqualone, a relatively new sedative hypnotic drug in the United States, has unique properties which make the handling of… 
1972
1972
A rapid gas-chromatographic method has been developed for the determination of butobarbitone, amylobarbitone, hexabarbitone… 
1970
1970
2-Methyl-3-o-tolyl-4 (3H)-quinazolinone (MTQ) was orally administered to human, and its urinary metabolites were examined. Two… 
1962
1962
  • Y. Duchastel
  • 1962
  • Corpus ID: 34692652
DURING the course of research on synthetic antimalarial drugs, Gujral, Saxena and Tiwari, in 19551 and 1956,2 noted that certain…